Position in BMRN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$8,780,179
New position
Shares Held
153,446
first reported quarter
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#121
of 561 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 85%
Shared 0%
None 15%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Boston Partners holds $329,375,186 across 6 Biotechnology names. BMRN ranks #4 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
2,773,568 | $217,087,166 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
718,574 | $58,614,080 | |
| 3 | INVA |
Innoviva, Inc.
|
1,927,959 | $43,783,948 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
153,446 | $8,780,179 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
30,481 | $1,109,813 | |
| 6 | 1,658,936 | $0 |
All Filings in BMRN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,780,179 | 153,446 | Shares | Defined | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||